Ocular toxicity after a single intravenous dose of desferrioxamine in 2 hemodialyzed patients. 1987

J Pengloan, and J Dantal, and C Rossazza, and M Abazza, and H Nivet

UI MeSH Term Description Entries
D003118 Color Perception Mental processing of chromatic signals (COLOR VISION) from the eye by the VISUAL CORTEX where they are converted into symbolic representations. Color perception involves numerous neurons, and is influenced not only by the distribution of wavelengths from the viewed object, but also by its background color and brightness contrast at its boundary. Color Perceptions,Perception, Color,Perceptions, Color
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014786 Vision Disorders Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision. These may result from EYE DISEASES; OPTIC NERVE DISEASES; VISUAL PATHWAY diseases; OCCIPITAL LOBE diseases; OCULAR MOTILITY DISORDERS; and other conditions (From Newell, Ophthalmology: Principles and Concepts, 7th ed, p132). Hemeralopia,Macropsia,Micropsia,Day Blindness,Metamorphopsia,Vision Disability,Visual Disorders,Visual Impairment,Blindness, Day,Disabilities, Vision,Disability, Vision,Disorder, Visual,Disorders, Visual,Hemeralopias,Impairment, Visual,Impairments, Visual,Macropsias,Metamorphopsias,Micropsias,Vision Disabilities,Vision Disorder,Visual Disorder,Visual Impairments

Related Publications

J Pengloan, and J Dantal, and C Rossazza, and M Abazza, and H Nivet
July 1983, Lancet (London, England),
J Pengloan, and J Dantal, and C Rossazza, and M Abazza, and H Nivet
January 1990, Nephron,
J Pengloan, and J Dantal, and C Rossazza, and M Abazza, and H Nivet
January 1987, Nephrologie,
J Pengloan, and J Dantal, and C Rossazza, and M Abazza, and H Nivet
January 1989, Acta otorrinolaringologica espanola,
J Pengloan, and J Dantal, and C Rossazza, and M Abazza, and H Nivet
April 1985, Lancet (London, England),
J Pengloan, and J Dantal, and C Rossazza, and M Abazza, and H Nivet
September 1991, Clinical nephrology,
J Pengloan, and J Dantal, and C Rossazza, and M Abazza, and H Nivet
July 2012, Indian journal of ophthalmology,
J Pengloan, and J Dantal, and C Rossazza, and M Abazza, and H Nivet
August 1983, Lancet (London, England),
J Pengloan, and J Dantal, and C Rossazza, and M Abazza, and H Nivet
January 1984, Transactions - American Society for Artificial Internal Organs,
J Pengloan, and J Dantal, and C Rossazza, and M Abazza, and H Nivet
July 1985, The Quarterly journal of medicine,
Copied contents to your clipboard!